Outcomes of Cardiac Resynchronization Therapy by New York Heart Association Class: A Patient-Level Meta-Analysis

Area of Science:

• Cardiology
• Heart Failure Management
• Medical Device Therapy

Background:

• Limited data exists on cardiac resynchronization therapy (CRT) benefits for severe heart failure symptoms.
• Investigated the comparative effects of CRT in ambulatory NYHA class IV versus class III heart failure patients.

Purpose of the Study:

• To compare the effectiveness of CRT in patients with New York Heart Association (NYHA) functional class IV versus class III heart failure.
• To determine if CRT offers differential benefits based on NYHA functional class at implantation.

Main Methods:

• Pooled patient-level data from MIRACLE, MIRACLE-ICD, and COMPANION trials.
• Utilized Bayesian hierarchical Weibull survival regression for outcome analysis.
• Assessed CRT association differences between NYHA III and IV groups via interaction term analysis.

Main Results:

• CRT was associated with longer time to heart failure hospitalization or all-cause mortality (aHR, 0.79; P=0.044).
• No significant difference in CRT's association with outcomes was found between NYHA III and IV functional classes (P > 0.23).
• Sensitivity analysis including RAFT data confirmed no significant relative CRT benefit difference between NYHA III and IV classes.

Conclusions:

• No significant difference in CRT's association with heart failure hospitalization or all-cause mortality was observed between NYHA functional class III and IV patients.
• The study suggests CRT effectiveness is comparable across these two NYHA functional classes.